Pelthos Therapeutics Inc. Common Stock (PTHS) — AI analysis & news
Pelthos Therapeutics Inc. Common Stock (PTHS) stock: 5 recent news items, slightly negative aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 5 indexed PTHS stories, aggregate finance-aware sentiment is slightly negative (-0.10 on a -1 to +1 scale).
Latest PTHS news
- Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock By Investing.com - Investing.com Canada · Investing.com Canada
- Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock By Investing.com - Investing.com India · Investing.com India
- Pelthos Therapeutics director sells $11,560 in common stock By Investing.com - Investing.com India · Investing.com India
- Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares By Investing.com - Investing.com UK · Investing.com UK
- Pelthos Therapeutics director Peter Greenleaf sells $16,872 in stock By Investing.com - Investing.com UK · Investing.com UK
FAQ
What is the current sentiment for PTHS stock?
Aggregate finance-aware sentiment across the last 5 indexed PTHS news stories is slightly negative (-0.10 on a -1 to +1 scale).